Roffman Miller Associates Inc Bristol Myers Squibb CO Transaction History

Roffman Miller Associates Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 16, 2021	SELL	$59.34 - $66.74 $393,839 - $442,953	-6,637 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $3,926 - $4,449	-68 Reduced 1.01%	6,637 $412,000
Q3 2020 Nov 06, 2020	SELL	$57.43 - $63.64 $78,334 - $86,804	-1,364 Reduced 16.9%	6,705 $404,000
Q2 2020 Nov 06, 2020	BUY	$54.82 - $64.09 $28,725 - $33,583	524 Added 6.94%	8,069 $474,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $65,980 - $95,885	-1,422 Reduced 15.86%	7,545 $421,000
Q4 2019 Jan 24, 2020	SELL	$49.21 - $64.19 $9,300 - $12,131	-189 Reduced 2.06%	8,967 $576,000
Q3 2019 Nov 04, 2019	SELL	$42.77 - $50.71 $1,839 - $2,180	-43 Reduced 0.47%	9,156 $464,000
Q2 2019 Aug 09, 2019	BUY	$44.62 - $49.34 $57,738 - $63,845	1,294 Added 16.37%	9,199 $417,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $356,673 - $425,289	7,905 New	7,905 $378,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $390,421 - $506,282	-8,007 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$55.19 - $62.25 $11,645 - $13,134	211 Added 2.71%	8,007 $497,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $6,013 - $7,494	-119 Reduced 1.5%	7,796 $431,000
Q1 2018 May 01, 2018	BUY	$59.92 - $68.98 $719 - $827	12 Added 0.15%	7,915 $501,000
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $8,451 - $9,214	-141 Reduced 1.75%	7,903 $484,000
Q3 2017 Nov 03, 2017	BUY	$55.23 - $63.74 $444,270 - $512,724	8,044	8,044 $513,000

2,444

1.51B

29.7M

32.1M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Roffman Miller Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Roffman Miller Associates Inc with notifications on news.